Dermatology · Ponce, PR
NPI
1306818638
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2431 Blvd Luis A Ferre Ste 104
Ponce, PR, 00717
Phone (787) 290-0141
Medicare paid, 2024
$10K
155 services
Medicare patients, 2024
66
Average age 76
Drug cost, 2024
$4.3M
2,803 prescriptions
Company payments, 2025
$561
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pedro Vendrell was code 99203 (office e&m - new), 36 times for 36 patients. In total Pedro Vendrell billed 155 services in 21 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99203 Office E&M - New | Office | 36 | 36 | $68.24 | $2,457 |
| 11102 Skin Biopsy | Office | 32 | 26 | $72.67 | $2,325 |
| 99213 Office E&M - Established | Office | 30 | 25 | $54.16 | $1,625 |
By year: 2022 $10K for 154 services; 2023 $10K for 160 services; 2024 $10K for 155 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pedro Vendrell prescribed most often to Medicare patients was Cephalexin, with 270 prescriptions and refills. In total Pedro Vendrell wrote 2,803 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cephalexin Generic | 270 | 270 | 233 | $2,450 |
| Ketoconazole Generic | 241 | 242 | 149 | $5,662 |
| Triamcinolone Acetonide Generic | 225 | 227 | 144 | $2,364 |
| Mometasone Furoate Generic | 192 | 193 | 122 | $4,628 |
| Famotidine Generic | 159 | 161 | 99 | $819 |
| Betamethasone Valerate Generic | 155 | 160 | 123 | $3,849 |
| Prednisone Generic | 144 | 146 | 104 | $815 |
| Minocycline Hcl Generic | 134 | 134 | 82 | $1,703 |
| Mupirocin Generic | 125 | 125 | 114 | $1,314 |
| Fluorouracil Generic | 107 | 117 | 88 | $9,091 |
| Skyrizi Pen Risankizumab-Rzaa | 103 | 273 | 30 | $2.2M |
| Terbinafine Hcl Generic | 83 | 83 | 54 | $964 |
| Fluconazole Generic | 81 | 81 | 61 | $913 |
| Taltz Autoinjector Ixekizumab | 73 | 73 | Under 11 | $526K |
| Doxycycline Monohydrate Generic | 68 | 68 | 42 | $944 |
Brand drugs: 537 claims; generic drugs: 2,266 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pedro Vendrell $561 ($561 in general payments such as food, travel and fees) from 10 companies. The largest payer was Janssen Biotech, Inc. with $172.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 2 | $172 |
| Amgen Inc. AMGN | 6 | $108 |
| Eli Lilly Export S.A. Puerto Rico Branch LLY | 3 | $63.66 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $62.07 |
| GlaxoSmithKline, LLC. GSK | 1 | $51.3 |
| Genzyme Corporation SNY | 2 | $47.34 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $20.73 |
| Pbg Puerto Rico LLC | 1 | $19.26 |
| Abbvie Inc. ABBV | 1 | $16.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.